146 related articles for article (PubMed ID: 10850895)
1. 1999: a time to re-evaluate AIDS vaccine strategies.
Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
[TBL] [Abstract][Full Text] [Related]
2. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
3. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
4. Australia reports on AIDS: nef deletions, live vaccines, Chinese travelers.
Mascolini M
J Int Assoc Physicians AIDS Care; 1996 Mar; 2(3):6-12, 40. PubMed ID: 11363347
[TBL] [Abstract][Full Text] [Related]
5. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
6. Reconsidering an attenuated vaccine for AIDS.
Beale J
Lancet; 1996 Feb; 347(8998):344-5. PubMed ID: 8598696
[No Abstract] [Full Text] [Related]
7. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.
Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT
J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165
[TBL] [Abstract][Full Text] [Related]
8. Attenuated HIV vaccine: caveats.
Ruprecht RM; Baba TW; Liska V
Science; 1996 Mar; 271(5257):1790-2. PubMed ID: 8596941
[No Abstract] [Full Text] [Related]
9. Immunization for long-term protection against AIDS using the macaque model.
Kumar A; Narayan O
Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799
[No Abstract] [Full Text] [Related]
10. Current status of the development of an AIDS vaccine.
Lasky LA
Crit Rev Immunol; 1989; 9(3):153-72. PubMed ID: 2673294
[TBL] [Abstract][Full Text] [Related]
11. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
Cohen J
Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
[No Abstract] [Full Text] [Related]
12. Developments in preclinical AIDS vaccine efficacy models.
Bogers WM; Cheng-Mayer C; Montelaro RC
AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
[No Abstract] [Full Text] [Related]
13. HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
Voronin Y; Phogat S
Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
[TBL] [Abstract][Full Text] [Related]
15. Aids vaccine advance.
Novak K; MacFarlane J; Aamodt S
Nat Med; 2000 Nov; 6(11):1220. PubMed ID: 11062531
[No Abstract] [Full Text] [Related]
16. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
[TBL] [Abstract][Full Text] [Related]
17. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine.
Desrosiers RC
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):331-2. PubMed ID: 8068412
[No Abstract] [Full Text] [Related]
18. [Development of an AIDS vaccine: status report].
Girard MP
Med Trop (Mars); 2007 Aug; 67(4):340-6. PubMed ID: 17926791
[TBL] [Abstract][Full Text] [Related]
19. The role of the SIV model in AIDS vaccine research.
Friedrich TC; Watkins DI
IAVI Rep; 2005; 9(2):1, 6-8. PubMed ID: 16156073
[No Abstract] [Full Text] [Related]
20. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
[Next] [New Search]